LF
AQST icon

LifeSteps Financial’s Aquestive Therapeutics AQST Stock Holding History

LifeSteps Financial’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12 Buy
+3
New +$13 ﹤0.01% 789

Other funds holding AQST

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
ACA
Adirondack Capital Advisors Syracuse, New York $186M AUM
CCM
Cox Capital Management Andover, Massachusetts $180M AUM 40.44% 1-Year Est. Return
LWA
Lineweaver Wealth Advisors Valley View, Ohio $845M AUM 20.71% 1-Year Est. Return
EC
Eleva Capital Paris, France $343M AUM
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

LifeSteps Financial's AQST Position: Q2 2026 in Review

LifeSteps Financial opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 3 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #789 among its holdings.

11 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • LifeSteps Financial held 3 shares of Aquestive Therapeutics worth $12 as of Q2 2026.
  • Aquestive Therapeutics was a new LifeSteps Financial position in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of LifeSteps Financial's portfolio in Q2 2026, its #789 holding.
  • 11 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.